XSHE
300249
Market cap1.08bUSD
Jul 09, Last price
16.04CNY
1D
5.25%
1Q
-4.92%
Jan 2017
19.06%
IPO
167.98%
Name
Yimikang Tech Group Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Yimikang Tech.Group Co., Ltd. is a Chinese enterprise primarily engaged in the development, production, and sale of advanced precision air conditioning solutions. Its comprehensive product portfolio includes precision air conditioners, micro-module and smart cabinets, magnetic suspension integrated cold stations, and intelligent control systems. Beyond its core air conditioning offerings, Yimikang also caters to the medical sector, supplying specialized equipment such as SHD modular operating room products designed for prefabricated modular inter-operators, intensive care units (ICUs), sterile supply departments (CSSDs), and laboratories, along with square tower shadowless lamps. Furthermore, the company contributes to environmental protection by manufacturing dust removal, desulfurization, and denitration equipment. Yimikang's diverse clientele spans numerous industries, including government, military, telecommunications, energy, power generation, transportation, healthcare, scientific research, and education. Established in 2002, the company maintains its headquarters in Chengdu, China. It initially operated as Sichuan Yimikang Environmental Tech. Co., Ltd. before officially adopting its current name, Yimikang Tech.Group Co., Ltd., in February 2018.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||